Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection

Improved Responses to Pegylated Interferon Alfa-2b and Ribavirin by Individualizing Treatment for 24–72 Weeks

(2011) Christoph Sarrazin et al.   GASTROENTEROLOGY

High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial)

(2011) Stéphane Chevaliez et al.   GASTROENTEROLOGY

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance

(2011) Julia di Iulio et al.   HEPATOLOGY

IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C

(2011) P.-Y. Bochud et al.   JOURNAL OF HEPATOLOGY

IL28B single nucleotide polymorphisms in the treatment of hepatitis C

(2011) Christian M. Lange et al.   JOURNAL OF HEPATOLOGY

Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C

(2011) J. Nattermann et al.   JOURNAL OF INFECTIOUS DISEASES

The role of genetic markers in hepatitis C virus therapy: a major step for individualized care

(2011) John G. McHutchison   LIVER INTERNATIONAL

IL28B SNP rs12979860 Is a Critical Predictor for On-Treatment and Sustained Virologic Response in Patients with Hepatitis C Virus Genotype-1 Infection

(2011) Chun-Yen Lin et al.   PLoS One

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

(2011) Katherine R Smith et al.   Genome Medicine

Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C

(2010) Albert Friedrich Stättermayer et al.   Clinical Gastroenterology and Hepatology

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

(2010) Alexander J. Thompson et al.   GASTROENTEROLOGY

A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice

(2010) Hans L. Tillmann et al.   GASTROENTEROLOGY

Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin

(2010) Jeanette J. McCarthy et al.   GASTROENTEROLOGY

Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C

(2010) Masao Honda et al.   GASTROENTEROLOGY

Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

(2010) Andri Rauch et al.   GASTROENTEROLOGY

IL28B and the Control of Hepatitis C Virus Infection

(2010) Ashwin Balagopal et al.   GASTROENTEROLOGY

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C

(2010) Thomas J. Urban et al.   HEPATOLOGY

Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection

(2010) Jason Grebely et al.   HEPATOLOGY

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

(2010) Norio Akuta et al.   HEPATOLOGY

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

(2010) Marco Antonio Montes-Cano et al.   HEPATOLOGY

IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy

(2010) Hiromi Abe et al.   JOURNAL OF HEPATOLOGY

IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway

(2010) Leiliang Zhang et al.   JOURNAL OF HEPATOLOGY

Type III IFNs: New layers of complexity in innate antiviral immunity

(2009) Nina Ank et al.   BIOFACTORS

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients

(2009) Thomas Berg et al.   HEPATOLOGY

Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family

(2009) Hans Henrik Gad et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C

(2009) Shinya Maekawa et al.   JOURNAL OF GASTROENTEROLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Host genetic determinants of spontaneous hepatitis C clearance

(2009) Andri Rauch et al.   PHARMACOGENOMICS

Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus

(2008) Chloe L. Thio   Clinics in Liver Disease

Human interferon-λ3 is a potent member of the type III interferon family

(2008) C Dellgren et al.   GENES AND IMMUNITY

Expert opinion on the treatment of patients with chronic hepatitis C

(2008) S. Zeuzem et al.   JOURNAL OF VIRAL HEPATITIS